Abstract
The sarcoidosis genetic analysis (SAGA) study previously identified eight chromosomal regions with suggestive evidence for linkage to sarcoidosis susceptibility in African-American sib pairs. Since the clinical course of sarcoidosis is variable and likely under genetic control, we used the affected relative pair portion of the SAGA sample (n=344 pairs) to perform multipoint linkage analyses with covariates based on pulmonary and organ involvement phenotypes. Chest radiographic resolution was the pulmonary phenotype with the highest LOD (logarithm of the backward odds, or likelihood ratio) score of 5.11 at D1S3720 on chromosome 1p36 (P=4 × 10−5). In general, higher LOD scores were attained for covariates that modeled clustered organ system involvement rather than individual organ systems, with the cardiac/renal group having the highest LOD score of 6.65 at chromosome 18q22 (P=2 × 10−5). The highest LOD scores for the other three organ involvement groups of liver/spleen/bone marrow, neuro/lymph and ocular/skin/joint were 3.72 at 10p11 (P=0.0004), 5.16 at 7p22 (P=4 × 10−5) and 2.93 at 10q26 (P=0.001), respectively. Most of the phenotype linkages did not overlap with the regions previously found linked to susceptibility. Our results suggest that genes influencing clinical presentation of sarcoidosis in African Americans are likely to be different from those that underlie disease susceptibility.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 6 digital issues and online access to articles
$119.00 per year
only $19.83 per issue
Rent or buy this article
Prices vary by article type
from$1.95
to$39.95
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Schurmann M, Reichel P, Muller-Myhsok B, Schlaak M, Muller-Quernheim J, Schwinger E . Results from a genome-wide search for predisposing genes in sarcoidosis. Am J Respir Crit Care Med 2001; 164: 840–846.
Valentonyte R, Hampe J, Huse K, Rosenstiel P, Albrecht M, Stenzel A et al. Sarcoidosis is associated with a truncating splice site mutation in BTNL2. Nat Genet 2005; 37: 357–364.
Iannuzzi, MC, Iyengar SK, Gray-McGuire C, Elston RC, Baughman RP, Donohue JF et al. Genome-wide search for sarcoidosis susceptibility genes in African Americans. Genes Immun 2005; 6: 509–518.
Grutters JC, Sato H, Welsh KI, du Bois RM . The importance of sarcoidosis genotype to lung phenotype. Am J Respir Cell Mol Biol 2003; 29: S59–S62.
Yamada R, Ymamoto K . Recent findings on genes associated with inflammatory disease. Mutat Res 2005; 573: 136–151.
Xing C, Gray-McGuire C, Kelly JA, Garriott P, Bukulmez H, Harley JB et al. Genetic linkage of systemic lupus erythematosus to 13q32 in African American families with affected male members. Hum Genet 2005; 118: 309–321.
Altmuller J, Seidel C, Lee YA, Loesgen S, Bulle D, Friedrichs F et al. Phenotypic and genetic heterogeneity in a genome-wide linkage study of asthma families. BMC Pulm Med 2005; 5: 1.
Mrazek F, Holla LI, Hutyrova B, Znojil V, Vasku A, Kolek V et al. Association of tumour necrosis factor-alpha, lymphotoxin-alpha and HLA-DRB1 gene polymorphisms with Lofgren's syndrome in Czech patients with sarcoidosis. Tissue Antigens 2005; 65: 163–171.
Berlin M, Fogdell-Hahn A, Olerup O, Eklund A, Grunewald J . HLA-DR predicts the prognosis in Scandinavian patients with pulmonary sarcoidosis. Am J Respir Crit Care Med 1997; 156: 1601–1605.
Swider C, Schnittger L, Bogunia-Kubik K, Gerdes J, Flad H, Lange A et al. TNF-alpha and HLA-DR genotyping as potential prognostic markers in pulmonary sarcoidosis. Eur Cytokine Netw 1999; 10: 143–146.
Sato H, Grutters JC, Pantelidis P, Mizzon AN, Ahmad T, van Houte AJ et al. HLA-DQB1*0201: a Marker for Good Prognosis in British and Dutch Patients with Sarcoidosis. Am J Respir Cell Mol Biol 2002; 27: 406–412.
Lofgren S . Erythema nodosum: studies on etiology and pathogenesis in 185 adult cases. Acta Med Scand 1946; 124: 1–197.
Grunewald J, Eklund A, Olerup O . Human leukocyte antigen class I alleles and the disease course in sarcoidosis patients. Am J Respir Crit Care Med 2004; 169: 696–702.
Martinetti M, Tinelli C, Kolek V, Cuccia M, Salvaneschi L, Pasturenzi L et al. The sarcoidosis map': a joint survey of clinical and immunogenetic findings in two European countries. Am J Respir Crit Care Med 1995; 152: 557–564.
Judson MA, Hirst K, Iyengar SK, Rybicki BA, El-Ghormli L, Baughman RP et al. Comparison of sarcoidosis phenotypes among affected African-American siblings. Chest 2006; 130: 855–862.
Sharma OP, Johnson CS, Balchum OJ . Familial sarcoidosis. Report of four siblings with acute sarcoidosis. Am Rev Respir Dis 1971; 104: 255–257.
Nassif X, Valeyre D, Loiseau A, Battesti JP . Familial sarcoidosis Apropos of 22 families. Ann Med Int (Paris) 1985; 136: 611–614.
Moura M, Carre P, Larios-Ramos L, Didier A, Leophonte P . Sarcoidosis and heredity 3. familial cases. Rev Pneumol Clin 1990; 46: 28–30.
Rybicki BA, Hirst K, Iyengar SK, Barnard JG, Judson MA, Rose CS et al. A sarcoidosis genetic linkage consortium: the sarcoidosis genetic analysis (SAGA) study. Sarcoidosis Vasc Diffuse Lung Dis 2005; 22: 115–122.
Reynolds HY . Sarcoidosis: impact of other illnesses on the presentation and management of multi-organ disease. Lung 2002; 180: 281–299.
Bowden DW, Colicigno CJ, Langefeld CD, Sale MM, Williams A, Anderson PJ et al. A genome scan for diabetic nephropathy in African Americans. Kidney Int 2004; 66: 1517–1526.
Vardarli I, Baier LJ, Hanson RL, Akkoyun I, Fischer C, Rohmeiss P et al. Gene for susceptibility to diabetic nephropathy in type 2 diabetes maps to 18q22.3–23. Kidney Int 2002; 62: 2176–2183.
Inagaki-Ohara K, Hanada T, Yoshimura A . Negative regulation of cytokine signaling and inflammatory diseases. Curr Opin Pharmacol 2003; 3: 435–442.
Bayle J, Letard S, Frank R, Dubreuil P, De SP . Suppressor of cytokine signaling 6 associates with KIT and regulates KIT receptor signaling. J Biol Chem 2004; 279: 12249–12259.
Langefeld CD, Davis CC, Brown WM . Nonparametric linkage regression. I: combined Caucasian CSGA and German genome scans for asthma. Genet Epidemiol 2001; 21 (Suppl 1): S136–S141.
Rossman MD, Thompson B, Frederick M, Maliarik M, Iannuzzi MC, Rybicki BA et al. HLA-DRB1*1101: a significant risk factor for sarcoidosis in blacks and whites. Am J Hum Genet 2003; 73: 720–735.
Just JJ, King MC, Thomson G, Klitz W . African-American HLA class II allele and haplotype diversity. Tissue Antigens 1997; 49: 547–555.
Zachary AA, Bias WB, Johnson A, Rose SM, Leffell MS . Antigen, allele, and haplotype frequencies report of the ASHI minority antigens workshops: part 1, African-Americans. Hum Immunol 2001; 62: 1127–1136.
Rybicki BA, Walewski JL, Maliarik MJ, Kian H, Iannuzzi MC . The BTNL2 Gene and Sarcoidosis Susceptibility in African Americans and Whites. Am J Hum Genet 2005; 77: 491–499.
Thompson CL, Rybicki BA, Iannuzzi MC, Elston RC, Iyengar SK, Gray-McGuire C et al. Reduction of Sample Heterogeneity through Use of Population Substructure: an example from a population of African American families with Sarcoidosis. Am J Hum Genet 2006; 79: 606–613.
SAGE. Statistical Analysis for Genetic Epidemiology. Release 5.3: 2006. http://genepi.cwru.edu/.
Olson JM . A general conditional-logistic model for affected-relative-pair linkage studies. Am J Hum Genet 1999; 65: 1760–1769.
Goddard KA, Witte JS, Suarez BK, Catalona WJ, Olson JM . Model-free linkage analysis with covariates confirms linkage of prostate cancer to chromosomes 1 and 4. Am J Hum Genet 2001; 68: 1197–1206.
Sinha M, Song Y, Elston RC, Olson JM, Goddard KA . Prediction of empirical p-values from asymptotic p-values for conditional logistic affected relative pair linkage analysis. Hum Hered 2006; 61: 45–54.
Scadding JG . Prognosis of intrathoracic sarcoidosis in England: a review of 136 cases after five years' observation. Br Med J 1961; 5261: 1165–1172.
Judson MA, Baughman RP, Teirstein AS, Terrin ML, Yeager Jr H . Defining organ involvement in sarcoidosis: the ACCESS proposed instrument. ACCESS Research Group. A Case Control Etiologic Study of Sarcoidosis. Sarcoidosis Vasc Diffuse Lung Dis 1999; 16: 75–86.
SAS Institute Inc. SAS/STAT Users's Guide, Version 8. SAS Institute Inc.: Cary, NC, USA, 1989, pp 4797–4828.
Acknowledgements
We thank all family members who participated in our study. This work was supported by National Institutes of Health Grants UO1 HL060263, GM28356 and P41 RR003655.
Author information
Authors and Affiliations
Consortia
Corresponding author
Additional information
Supplementary Information accompanies the paper on Genes and Immunity website (http://www.nature.com/gene)
Supplementary information
Rights and permissions
About this article
Cite this article
Rybicki, B., Sinha, R., Iyengar, S. et al. Genetic linkage analysis of sarcoidosis phenotypes: the sarcoidosis genetic analysis (SAGA) study. Genes Immun 8, 379–386 (2007). https://doi.org/10.1038/sj.gene.6364396
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/sj.gene.6364396
Keywords
This article is cited by
-
Multiple Correspondence Analysis and HLA-Associations of Organ Involvement in a Large Cohort of African-American and European-American Patients with Sarcoidosis
Lung (2023)
-
Whole-exome sequencing identifies rare genetic variations in German families with pulmonary sarcoidosis
Human Genetics (2018)
-
RNA-sequencing Identifies Novel Pathways in Sarcoidosis Monocytes
Scientific Reports (2017)
-
Sarkoidose
Zeitschrift für Rheumatologie (2017)
-
Genetisches Risikoprofil der Sarkoidose
Der Internist (2014)